default author photo

Jianya Zhou

Zhejiang University - The First Affiliated Hospital

SCHOLARLY PAPERS

2

DOWNLOADS

163

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy of Pembrolizumab as Treatment Beyond Failure of First-Line Treatment in Stage IV Non-Small Cell Lung Cancer: A Real-World Study

Number of pages: 24 Posted: 15 May 2023
Zhejiang University - The First Affiliated Hospital, Jiaxing University - First Affiliated Hospital, Zhejiang Jinhua Guangfu Tumor Hospital, Zhejiang University - The First Affiliated Hospital, Zhuji People's Hospital of Zhejiang Province, Lishui Central Hospital, Lihuili Hospital - Ningbo Medical Center, Huzhou Central Hospital, People’s Hospital of Shengzhou, Quzhou People's Hospital, Ningbo First Hospital, Cixi people's Hospital, Wenzhou Medical University - Affiliated Taizhou Hospital, Zhejiang University - The First Affiliated Hospital, Zhejiang University - The First Affiliated Hospital and Zhejiang University - The First Affiliated Hospital
Downloads 86 (765,566)

Abstract:

Loading...

Pembrolizumab, non-small cell lung cancer, Treatment beyond failure of first-line treatment, Real-world study

2.

CXCR6-Positive Circulating Mucosal-Associated Invariant T Cells Can Identify Patients with Non-Small Cell Lung Cancer Responding to Anti-PD-1 Immunotherapy

Number of pages: 33 Posted: 08 Feb 2024
Zhejiang University, Zhejiang University, Zhejiang University - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University, Central South University - Hunan Cancer Hospital, Zhejiang University and Zhejiang University - The First Affiliated Hospital
Downloads 77 (830,555)

Abstract:

Loading...

Circulating mucosal-associated invariant T cells, CXCR6, Non-small cell lung cancer, Single-cell RNA-sequencing, Immunotherapy